COVID-19 was third leading cause of death in the United States in both 2020 and 2021
On Jul. 5, 2022, the National Institutes of Health and National Cancer Institute announced COVID-19 was the third…
On Jul. 5, 2022, the National Institutes of Health and National Cancer Institute announced COVID-19 was the third…
On Jun. 28, 2022, the National Institutes of Health (NIH) announced that a Phase 1 clinical trial of…
Play the COVID-19 Wheel of Fortune and see how lucky you are! You have two wheels to choose…
On Jun. 2, 2022, the National Institutes of Health (NIH) reported that the Age-Related Eye Disease Studies (AREDS…
On Jun. 1, 2022, the U.S. National Institutes of Health (NIH) announced that an NIH funded study had…
On May 25, 2022, the Health and Human Services agency (HHS) announced the formal establishment of the Advanced…
On May 19, 2022, the U.S. National Institutes of Health (NIH) announced that people who reported in a…
On May 18, 2022, the U.S. National Institutes of Health announced it had awarded approximately $577 million to…
On May 17, 2022, OraSure Technologies announced that its InteliSwab COVID-19 rapid tests detect the Omicron BA.2, BA.2.12.1,…
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
On Apr. 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
On Mar. 31, 2022, the National Institutes of Health (NIH) and Moderna announced a phase 2 clinical trial…
On Mar. 17, 2022, the National Institutes of Health announced that nearly 100,000 highly diverse whole genome sequences…
On Mar. 14, 2022, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) announced they had…
On Mar. 10, 2022, schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…
On Mar. 22, 2022, Novavax and Serum Institute of India announced that the Drugs Controller General of India…
On Feb. 8, 2022, Merck and Ridgeback Biotherapeutics announced that a total of 3.1 million courses of molnupiravir,…
On Feb. 4, 2022, the NIH announced a study that showed pregnant women with COVID-19 appeared to be…
On Feb. 4, 2022, the NIH reported that Staphylococcus epidermidis produces enzymes, known as sphingomyelinase, that help the…
On Feb. 2, 2022, President Biden announced a reignition of the Cancer Moonshot, that highlighted new goals: to…
On Jan. 26, 2022, the NIH announced that adults who had previously received a full regimen of any…
On Jan. 20, 2022, scientists from the National Institute of Allergy and Infectious Diseases (NIAID) announced that they…
On Jan. 20, 2022, the National Institutes of Health announced it was awarding $170 million over five years,…
On Jan 5, 2022, NRx Pharmaceuticals announced that it had submitted an application for Emergency Use Authorization (EUA)…
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
On Dec. 16, 2021, NIH scientists announced that to counter future coronavirus outbreaks, the global scientific and medical…
On Dec. 3, 2021, a report from the U.S. Department of Health and Human Services (HHS) found that…
The COVID-19 Roller Coaster is a wild ride! Strap yourself in and hold on for the ride of…
Our Life-Saving Vaccines cartoon illustrates four invaluable vaccines that have affected human civilization throughout history from smallpox and…
On Oct. 18, 2021, the National Institutes of Health launched a program to study a rare type of…